Moving East: the Euro-Lupus Nephritis regimen in Asia.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 26759044.
- Also identified by DOI 10.1016/j.kint.2015.11.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment of lupus nephritis is more evidenced-based than ever. Yet many areas of uncertainty persist. The article by Rathi et al. brings a piece to the puzzle by comparing, in a group of Indian patients, the Euro-Lupus low-dose i.v. cyclophosphamide regimen with mycophenolate mofetil. Although some caveats must be raised, the results suggest that, after crossing the Atlantic, the Euro-Lupus regimen may well be moving East.
Medical subject headings
- Immunosuppressive Agents
- Lupus Nephritis